Your browser doesn't support javascript.
loading
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.
Costa, Luciano J; Maddocks, Kami; Epperla, Narendranath; Reddy, Nishitha M; Karmali, Reem; Umyarova, Elvira; Bachanova, Veronika; Costa, Cristiana; Glenn, Martha J; Chavez, Julio C; Calzada, Oscar; Lansigan, Frederick; Nasheed, Hossain; Barta, Stefan K; Zhou, Zheng; Jaglal, Michael; Chhabra, Saurabh; Hernandez-Ilizaliturri, Francisco; Xavier, Ana C; Mehta, Amitkumar; Peker, Deniz; Forero-Torres, Andreas; Al-Mansour, Zeina; Evens, Andrew M; Cohen, Jonathon B; Flowers, Christopher R; Fenske, Timothy S; Hamadani, Mehdi.
Afiliación
  • Costa LJ; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Maddocks K; Division of Hematology, Ohio state University, Columbus, Ohio, USA.
  • Epperla N; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Reddy NM; Division of Hematology and Oncology, Vanderbilt University, Nashville, Tennessee, USA.
  • Karmali R; Division of Hematology, Oncology and Cell Therapy, Rush University, Chicago, Illinois, USA.
  • Umyarova E; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
  • Costa C; Department of Hematology and Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Glenn MJ; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, Utah, USA.
  • Chavez JC; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research, Tampa, Florida, USA.
  • Calzada O; Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, Georgia, USA.
  • Lansigan F; Department of Hematology and Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Nasheed H; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Barta SK; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Zhou Z; Division of Hematology-Oncology, University of Massachusetts, Worcester, Massachusetts, USA.
  • Jaglal M; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research, Tampa, Florida, USA.
  • Chhabra S; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Hernandez-Ilizaliturri F; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Xavier AC; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Mehta A; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Peker D; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Forero-Torres A; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Al-Mansour Z; Division of Hematology/Oncology, Tufts University, Boston, Massachusetts, USA.
  • Evens AM; Division of Hematology/Oncology, Tufts University, Boston, Massachusetts, USA.
  • Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, Georgia, USA.
  • Flowers CR; Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, Georgia, USA.
  • Fenske TS; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Hamadani M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Am J Hematol ; 92(2): 161-170, 2017 Feb.
Article en En | MEDLINE | ID: mdl-27880984
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Terapia Recuperativa / Trasplante de Células Madre Hematopoyéticas / Progresión de la Enfermedad Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Terapia Recuperativa / Trasplante de Células Madre Hematopoyéticas / Progresión de la Enfermedad Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos